The ESG develops a free of charge online updating program for women’s health HCPs.
Each month 2 keynote speakers will discuss on a range of topics devoted to improving your knowledge and professional development in your daily clinical practice.
Additionally, you will have the opportunity to participate in live question and answer sessions.These monthly resources provide you with invaluable and engaging insights covering a wide spectrum of subjects, including Breast Cancer, IVF, Pregnancy, Hypotalamic Amenorrhea, Gynecologial Oncology, Genital Infections and many others.
To access the library of on-demand webinars available anytime, please click on “Past webinars”.
UPCOMING WEBINARS
PAST WEBINARS
UPCOMING WEBINARS
PAST WEBINARS
Tailoring endometrial cancer prevention and treatment in current medical practice
15-Jan-2025 15:00–16:30
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Andrea Giannini
Intercepting endometrial cancer risk factors across the women’s life
Intercepting endometrial cancer risk factors across the women’s life
Dr. Francesco Multinu and Dr. Ida Pino
Conservative treatment of endometrial preneoplastic and neoplastic diseases in fertile women
Conservative treatment of endometrial preneoplastic and neoplastic diseases in fertile women
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Jonathan Douxfils
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
Prof. Nathalie Chabbert-Buffet
DVT in Contraception
DVT in Contraception
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Pedro Barri
Embryo mosaicism. Basis and clinical decisions
Embryo mosaicism. Basis and clinical decisions
Prof. Ana Teresa Almeida Santos
Fertility preservation in Ovarian Cancer
Fertility preservation in Ovarian Cancer
Prof. Andrea Genazzani
Chairman
Chairman
Prof. Blazej Meczekalski
Challenges in diagnosis and long-term consequences on FHA
Challenges in diagnosis and long-term consequences on FHA
Prof. Alessandro Genazzani
Treatment approach to FHA
Treatment approach to FHA
Prof. Kristina Gemzell-Danielsson
Chairman
Chairman
Prof. Kristina Gemzell-Danielsson
Compliance for real-life effectiveness
Compliance for real-life effectiveness
Prof. Franca Fruzzetti
Woman and the right estrogen – an indissoluble combination in contraception
Woman and the right estrogen – an indissoluble combination in contraception
Prof. Terhi Piltonen
Insights from the estetrol/drospirenone clinical trials
Insights from the estetrol/drospirenone clinical trials
Prof. Jonathan Douxfils
Hemostasis parameters with estetrol/drospirenone – why APC resistance matters
Hemostasis parameters with estetrol/drospirenone – why APC resistance matters
Prof. Tommaso Simoncini
A new horizon in combined hormonal contraception and beyond
A new horizon in combined hormonal contraception and beyond
Prof. Paolo Mannella
Chairman
Chairman
Prof. Pavel Calda
Diagnostic and management of PAS
Diagnostic and management of PAS
Prof. Frederic Chantraine
How to prepare for Delivery
How to prepare for Delivery
Prof. Antonio Cano
Chairman
Chairman
Prof. Andrzej Milewicz
Metabolic diseases and Menopause
Metabolic diseases and Menopause
Prof. Alfred Mueck
Individualized MHT to optimise vascular and metabolic effects
Individualized MHT to optimise vascular and metabolic effects
Prof. Andrea R. Genazzani
Chairman
Chairman
Prof. Sophie Christin Maitre
Sub clinical Hypothyroidism in the context of infertility and pregnancy.
Sub clinical Hypothyroidism in the context of infertility and pregnancy.
Prof. Andrzej Milewicz
Impact of Hyperthyroidism in reproduction: from diagnosis to therapies.
Impact of Hyperthyroidism in reproduction: from diagnosis to therapies.
Prof. Andrea R. Genazzani
Chairman
Chairman
Prof. Tommaso Simoncini
Vasomotor Symptoms: a marker of postmenopausal risks
Vasomotor Symptoms: a marker of postmenopausal risks
Prof. Herman Depypere
NKR antagonists for vasomotor symptoms treatment
NKR antagonists for vasomotor symptoms treatment 







